Biological actions of cholecystokinin

Cholecystokinin (CCK) has emerged as an important mammalian neuropeptide, localized in peripheral organs and in the central nervous system. This review presents an overview of the molecular aspects of CCK peptides and CCK receptors, the anatomical distribution of CCK, the neurophysiological actions of CCK, release of CCK and effects of CCK on release of other neurotransmitters, and the actions of CCK on digestion, feeding, cardiovascular function, respiratory function, neurotoxicity and seizures, cancer cell proliferation, analgesia, sleep, sexual and reproductive behaviors, memory, anxiety, and dopamine-mediated exploratory and rewarded behaviors. Human clinical studies of CCK in feeding disorders and panic disorders are described. New findings are presented on potent, nonpeptide CCK antagonists, selective for the two CCK receptor subtypes, which demonstrate that endogenous CCK has biologically important effects on physiology and behavior.

[1]  J. Rehfeld,et al.  Cholecystokinin and vasoactive intestinal polypeptide in the mammalian CNS: distribution and possible physiological roles. , 1980, Advances in biochemical psychopharmacology.

[2]  O. Wolkowitz,et al.  Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist , 1990, Biological Psychiatry.

[3]  W. Laughton,et al.  Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice. , 1992, The American journal of physiology.

[4]  J. Vanderhaeghen,et al.  New peptide in the vertebrate CNS reacting with antigastrin antibodies , 1975, Nature.

[5]  D. K. Meyer,et al.  Effects of unilateral cortex lesions on gene expression of rat cortical cholecystokinin neurons. , 1991, Brain research. Molecular brain research.

[6]  R. Yalow,et al.  Brain cholecystokinin in fasted and fed mice. , 1980, Life sciences.

[7]  J. Féger,et al.  Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264 , 1990, Synapse.

[8]  R. Yalow,et al.  Cholecystokinin octapeptides purified from chinchilla and chicken brains , 1987, Brain Research Bulletin.

[9]  Systemic administration of a cholecystokinin analogue, ceruletide, protects against ischemia-induced neurodegeneration in gerbils. , 1992, European journal of pharmacology.

[10]  John D. Minna,et al.  Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer , 1985, Nature.

[11]  J. Morley,et al.  Cholecystokinin receptors mediate enhanced memory retention produced by feeding and gastrointestinal peptides , 1989, Peptides.

[12]  G. P. Smith,et al.  Endogenous cholecystokinin does not decrease food intake or gastric emptying in fasted rats. , 1989, The American journal of physiology.

[13]  S. Woods,et al.  Intraventricular CCK inhibits food intake and gastric emptying in baboons. , 1989, The American journal of physiology.

[14]  C. Baile,et al.  Changes in brain CCK concentrations with peripheral CCK injections in Zucker rats , 1986, Physiology & Behavior.

[15]  T. Davidson,et al.  Cholecystokinin, but not bombesin, has interoceptive sensory consequences like 1-h food deprivation , 1993, Physiology & Behavior.

[16]  J. Davison,et al.  Dibutyryl cyclic GMP, a competitive inhibitor of cholecystokinin/pancreozymin and related peptides in the gallbladder and ileum. , 1981, Canadian journal of physiology and pharmacology.

[17]  J. Walsh,et al.  Cholecystokinin receptor antagonist MK-329 blocks intestinal fat-induced inhibition of meal-stimulated gastric acid secretion. , 1992, Gastroenterology.

[18]  G. D'mello,et al.  Oral Self-Administration and the Relevance of Conditioned Taste Aversions , 1981 .

[19]  Kathleen A. Marshall,et al.  Lithium chloride, cholecystokinin and meal patterns: Evidence that cholecystokinin suppresses meal size in rats without causing malaise , 1987, Appetite.

[20]  C. Owyang,et al.  Feedback regulation of pancreatic enzyme secretion. Suppression of cholecystokinin release by trypsin. , 1986, The Journal of clinical investigation.

[21]  S. Peikin,et al.  Action of the cholecystokinin antagonist L364,718 on gastric emptying in the rat. , 1988, The American journal of physiology.

[22]  D. S. Zahm,et al.  Specificity in the projection patterns of accumbal core and shell in the rat , 1991, Neuroscience.

[23]  M. Forsling,et al.  The effects of intravenous administration of cholecystokinin on feeding behaviour and release of pituitary hormones in pigs are not mediated by serotonergic (5-HT3) receptors , 1992, Neuropharmacology.

[24]  R. Jensen,et al.  Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Rehfeld,et al.  A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: Evidence from immunohistochemistry combined with retrograde tracing , 1980, Neuroscience.

[26]  G. P. Smith,et al.  Pharmacological examination of cholecystokinin (CCK-8)-induced contractile activity in the rat isolated pylorus , 1987, Peptides.

[27]  K. Pirke,et al.  Disturbed cholecystokinin secretion in patients with eating disorders. , 1991, Life sciences.

[28]  M. Denavit-Saubié,et al.  Different targets involved in the effect of cholecystokinin on respiration. , 1985, European journal of pharmacology.

[29]  G. Zetler,et al.  Antinociceptive effect of centrally administered caerulein and cholecystokinin octapeptide (CCK-8)☆ , 1981 .

[30]  G. Woodruff,et al.  Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  CCK modulates inhibitory synaptic transmission in the solitary complex through CCKB sites. , 1992, Neuroreport.

[32]  J. Howbert,et al.  Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons. , 1993, The Journal of pharmacology and experimental therapeutics.

[33]  S. Itoh,et al.  Effect of caerulein on plasma corticosterone concentration in the rat. , 1980, Life sciences.

[34]  B. Bunney,et al.  Activity of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin , 1987, Brain Research.

[35]  J. Quest,et al.  Activation of central nervous system cholecystokinin receptors stimulates respiration in the cat. , 1983, The Journal of pharmacology and experimental therapeutics.

[36]  S. Iversen,et al.  Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260. , 1991, European journal of pharmacology.

[37]  L. Belbeck,et al.  The effects of proglumide on cholecystokinin-, bombesin-, and glucagon-induced satiety in the rat. , 1983, Life sciences.

[38]  B. Roques,et al.  Autoradiographic localization of cholecystokinin binding sites in human cerebellar system using a [125I]CCK8 probe , 1987, Neurochemistry International.

[39]  M. Grossman,et al.  Inhibition of gastric acid secretion in man by peptide analogues of cholecystokinin. , 1970, The New England journal of medicine.

[40]  B. Bianchi,et al.  Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors. , 1991, Molecular pharmacology.

[41]  D. Hommer,et al.  Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat , 1985, Brain Research.

[42]  B. Zheng,et al.  Brain/gut peptides in fed and fasted rats. , 1987, Endocrinology.

[43]  T. Hökfelt,et al.  Expression and localization of gastrin messenger RNA and peptide in spermatogenic cells. , 1990, The Journal of clinical investigation.

[44]  P. Micevych,et al.  Role of perinatal estrogens in sexual differentiation of the inhibition of lordosis by exogenous cholecystokinin , 1993, Physiology & Behavior.

[45]  S. Iversen,et al.  Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors. , 1989, Science.

[46]  W. Creutzfeldt,et al.  Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats. , 1987, Gastroenterology.

[47]  T. Ott,et al.  CCK-8 modulates D2 receptor agonist-induced hypermotility in the nucleus accumbens , 1991, Brain Research Bulletin.

[48]  J M Liesch,et al.  A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus. , 1985, Science.

[49]  R. W. Sikes,et al.  Effects of CCK-8 in the nucleus accumbens , 1984, Peptides.

[50]  X. Pi-Sunyer,et al.  C-Terminal octapeptide of cholecystokinin decreases food intake in obese men , 1982, Physiology & Behavior.

[51]  W. Creutzfeldt,et al.  Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. , 1991, The American journal of physiology.

[52]  S. Iversen,et al.  Blockade of CCK-B receptors by L-365,260 induces analgesia in the squirrel monkey , 1990, Brain Research.

[53]  李幼升,et al.  Ph , 1989 .

[54]  H. Debas,et al.  Inhibition of gastric emptying is a physiological action of cholecystokinin. , 1975, Gastroenterology.

[55]  S. Matsukura,et al.  Changes in plasma cholecystokinin concentrations after oral glucose tolerance test in anorexia nervosa before and after therapy. , 1993, Metabolism: clinical and experimental.

[56]  T. Moody,et al.  High affinity binding of cholecystokinin to small cell lung cancer cells , 1987, Peptides.

[57]  C. Logsdon Stimulation of pancreatic acinar cell growth by CCK, epidermal growth factor, and insulin in vitro. , 1986, The American journal of physiology.

[58]  J. Battey,et al.  Differential Gene Expression of CCKA and CCKB Receptors in the Rat Brain , 1993, Molecular and Cellular Neuroscience.

[59]  T. Westfall,et al.  Cholecystokinin octapeptides alter the release of endogenous dopamine from the rat nucleus accumbens in vitro. , 1986, The Journal of pharmacology and experimental therapeutics.

[60]  T. Shiraishi CCK as a central satiety factor: Behavioral and electrophysiological evidence , 1990, Physiology & Behavior.

[61]  M. Peschanski,et al.  Postnatal development of cholecystokinin (CCK) binding sites in the rat forebrain and midbrain: an autoradiographic study. , 1988, Brain research. Developmental brain research.

[62]  S. Butcher,et al.  In vivo studies on the enhancement of cholecystokinin release in the rat striatum by dopamine depletion , 1989, Brain Research.

[63]  J. Crawley,et al.  Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens , 1990, Brain Research.

[64]  T. Dunwiddie,et al.  Cholecystokinin potentiates dopamine inhibition of mesencephalic dopamine neurons in vitro , 1987, Brain Research.

[65]  T. Hökfelt,et al.  Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection. , 1980, European journal of pharmacology.

[66]  F. Vandesande,et al.  Cholecystokinin varies in the posterior pituitary and external median eminence of the rat according to factors affecting vasopressin and oxytocin. , 1983, Life sciences.

[67]  F. Makovec,et al.  New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activity. , 1985, Arzneimittel-Forschung.

[68]  B. Balkan,et al.  Hepatic-portal and cardiac infusion of CCK-8 and glucagon induce different effects on feeding , 1989, Physiology & Behavior.

[69]  Y. Taché,et al.  Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats. , 1988, The American journal of physiology.

[70]  R. Jorde,et al.  Plasma cholecystokinin (CCK) before and after a jejunoileal bypass operation in obese patients with reference to appetite regulation. , 1984, International journal of obesity.

[71]  A. Deutch,et al.  Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell , 1992, Neuroscience.

[72]  G. Bray,et al.  Cholecystokinin and satiety: effect of hypothalamic obesity and gastric bubble insertion. , 1992, The American journal of physiology.

[73]  C. Defilippi,et al.  Inhibition of gastric emptying in humans by secretion, the octapeptide of cholecystokinin, and intraduodenal fat. , 1981, Gastroenterology.

[74]  J. Davison,et al.  The effect of vagotomy on the increase in food intake induced by the cholecystokinin antagonist, proglumide , 1985, Regulatory Peptides.

[75]  P. Wood,et al.  Effect of cholecystokinin on acetylcholine turnover and dopamine release in the rat striatum and cortex. , 1989, European journal of pharmacology.

[76]  R. Jensen,et al.  Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[77]  G. Mogenson,et al.  Effects of dopamine agonists on excitatory inputs to nucleus accumbens neurons from the amygdala: modulatory actions of cholecystokinin , 1991, Brain Research.

[78]  L. Bednarz,et al.  Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats , 1992, Brain Research.

[79]  A. Phillips,et al.  Cholecystokinin facilitates ejaculation in male rats: blockade with proglumide and apomorphine. , 1987, European journal of pharmacology.

[80]  C. Blaha,et al.  In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens , 1986, Brain Research.

[81]  L. Bednarz,et al.  A-71623, a selective CCK-A receptor agonist, suppresses food intake in the mouse, dog, and monkey , 1992, Pharmacology Biochemistry and Behavior.

[82]  J. Crawley Cholecystokinin-dopamine intearctions , 1991 .

[83]  S. Cooper,et al.  Fluoxetine reduces food intake by a cholecystokinin-independent mechanism , 1990, Pharmacology Biochemistry and Behavior.

[84]  R. Chang,et al.  Characterization of the binding of [3H]-(+/-)-L-364,718: a new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors. , 1986, Molecular pharmacology.

[85]  R. Jensen,et al.  Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[86]  J. Féger,et al.  CCK8 effects on motivational and emotional states of rats involve CCKA receptors of the postero-median part of the nucleus accumbens , 1989, Pharmacology Biochemistry and Behavior.

[87]  T. Chase,et al.  A comparison of peripheral and central effects of CCK8 on water-reinforced operant responding. , 1985, European journal of pharmacology.

[88]  J. Crawley Comparative Distribution of Cholecystokinin and Other Neuropeptides , 1985, Annals of the New York Academy of Sciences.

[89]  S. Iversen,et al.  CCK-8 modulation of mesolimbic dopamine: Antagonism of amphetamine-stimulated behaviors , 1983, Peptides.

[90]  O. Prospero-Garcia,et al.  Cerebroventricular infusion of cholecystokinin (CCK-8) restores REM sleep in parachlorophenylalanine (PCPA)-pretreated cats , 1987, Neuroscience Letters.

[91]  F. J. White,et al.  Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons , 1984, Brain Research.

[92]  T. Hökfelt,et al.  PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[93]  R. Reidelberger,et al.  Effects of selective cholecystokinin antagonists L364,718 and L365,260 on food intake in rats , 1991, Peptides.

[94]  J. Rehfeld,et al.  Radioimmunoassay of cholecystokinin in human plasma. , 1981, Clinica chimica acta; international journal of clinical chemistry.

[95]  R. Hill,et al.  Antagonism of central and peripheral anorectic effects of caerulein by L-364,718. , 1989, European journal of pharmacology.

[96]  A. Sandvik,et al.  CCK-B (gastrin) receptor regulates gastric histamine release and acid secretion. , 1991, The American journal of physiology.

[97]  R. Reidelberger,et al.  Plasma CCK levels after food intake and infusion of CCK analogues that inhibit feeding in dogs. , 1989, The American journal of physiology.

[98]  V. Go,et al.  Neuronal cholecystokinin-like immunoreactivity is postprandially released from primate hypothalamus , 1987, Brain Research.

[99]  R. Chang,et al.  Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[100]  C. Baile,et al.  CNS injection of CCK in rats: effects on real and sham feeding and gastric emptying. , 1990, The American journal of physiology.

[101]  D. Dahl Systemically administered cholecystokinin affects an evoked potential in the hippocampal dentate gyrus , 1987, Neuropeptides.

[102]  S. Konturek,et al.  Cholecystokinin receptors and vagal nerves in control of food intake in rats. , 1990, The American journal of physiology.

[103]  J. Born,et al.  Effects of cholecystokinin and calcitonin on evoked brain potentials and satiety in man , 1989, Physiology & Behavior.

[104]  Menek Goldstein,et al.  Chapter 4 Coexistence of neuronal messengers — an overview , 1986 .

[105]  J. Walsh,et al.  Molecular heterogeneity of canine cholecystokinin in portal and peripheral plasma , 1984, Regulatory Peptides.

[106]  G. P. Smith,et al.  Intravenous infusion of CCKA-receptor antagonist increases food intake in rats. , 1992, The American journal of physiology.

[107]  Pendleton Rg,et al.  Effect of metoclopramide, bethanechol and the cholecystokinin receptor antagonist, L-364,718, on gastric emptying in the rat , 1988 .

[108]  J. Vanderhaeghen,et al.  Distribution of immunoreactive cholecystokinin in the human hippocampus , 1987, Peptides.

[109]  R J Gould,et al.  In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist. , 1987, The Journal of pharmacology and experimental therapeutics.

[110]  C. Altar,et al.  Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine release , 1988, Brain Research.

[111]  I. Goldfine,et al.  Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. , 1985, The Journal of clinical investigation.

[112]  Y. Kubota,et al.  Ontogeny of cholecystokinin‐8‐containing neuron system of the rat: An immunohistochemical analysis. I. Forebrain and upper brainstem , 1983, The Journal of comparative neurology.

[113]  S. Efendić,et al.  Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats. , 1982, Endocrinology.

[114]  D. Rees,et al.  Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and "mixed" CCK-A/CCK-B antagonists. , 1993, Journal of medicinal chemistry.

[115]  B. Roques,et al.  Neuroleptic-like properties of cholecystokinin analogs: Distinctive mechanisms underlying similar behavioral profiles depending on the route of administration , 1988, Peptides.

[116]  P. McHugh,et al.  Blockade of type A, but not type B, CCK receptors postpones satiety in rhesus monkeys. , 1993, The American journal of physiology.

[117]  D. K. Meyer,et al.  Effects of selective dopamine D2-receptor agonists on the release of cholecystokinin-like immunoreactivity from rat neostriatum. , 1984, European journal of pharmacology.

[118]  G. Mogenson,et al.  Electrophysiological evidence of modulatory interaction between dopamine and cholecystokinin in the nucleus accumbens , 1991, Brain Research.

[119]  J. Rehfeld,et al.  Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog. , 1978, The Journal of biological chemistry.

[120]  J. Morley,et al.  Evidence that cholecystokinin-enhanced retention is mediated by changes in opioid activity in the amygdala , 1992, Brain Research.

[121]  R. Ritter,et al.  Dorsomedial hindbrain participation in cholecystokinin-induced satiety. , 1986, The American journal of physiology.

[122]  J. Davison,et al.  The cholecystokinin antagonist, proglumide, increases food intake in the rat , 1984, Regulatory Peptides.

[123]  R. Jensen,et al.  Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists. , 1983, The Journal of biological chemistry.

[124]  W. Chey,et al.  Effect of secretin and cholecystokinin on gastric emptying and gastric secretion in man. , 1970, Gastroenterology.

[125]  R. Unger,et al.  Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide. , 1977, The Journal of clinical investigation.

[126]  Trevor W. Robbins,et al.  Cholecystokinin-dopamine interactions within the nucleus accumbens in the control over behaviour by conditioned reinforcement , 1993, Behavioural Brain Research.

[127]  P. Miller,et al.  Cholecystokinin mediates feedback regulation of pancreatic enzyme secretion in rats. , 1986, The American journal of physiology.

[128]  M. Grossman,et al.  Effect of secretin and cholecystokinin on pentagastrin-stimulated gastric secretion in man. , 1970, Gastroenterology.

[129]  D. K. Meyer,et al.  Dopamine modulates cholecystokinin release in neostriatum , 1983, Nature.

[130]  C. Jacquot,et al.  Variability of changes in obese rat brain monoamines in response to cholecystokinin. , 1986, General pharmacology.

[131]  A. Steggles,et al.  Characterization of Cholecystokinin Binding Sites in Rat Cerebral Cortex Using a 125I‐CCK‐8 Probe Resistant to Degradation , 1983, Journal of neurochemistry.

[132]  P. Maton,et al.  Large and small forms of cholecystokinin in human plasma: measurement using high pressure liquid chromatography and radioimmunoassay , 1982, Regulatory Peptides.

[133]  B. A. Baldwin,et al.  Operant feeding and drinking in pigs following intracerebroventricular injection of synthetic cholecystokinin octapeptide , 1981, Physiology & Behavior.

[134]  H. Raybould,et al.  Cholecystokinin inhibits gastric acid secretion through type "A" cholecystokinin receptors and somatostatin in rats. , 1992, The American journal of physiology.

[135]  L. Chiodo,et al.  Receptor selectivity of cholecystokinin effects on mesoaccumbens dopamine neurons , 1991, Synapse.

[136]  B. Penke,et al.  Inhibition of seizures induced by picrotoxin and electroshock by cholecystokinin octapeptides and their fragments in rats after intracerebroventricular administration , 1984, Neuropharmacology.

[137]  H. Raper,et al.  Pancreozymin, a stimulant of the secretion of pancreatic enzymes in extracts of the small intestine , 1943, The Journal of physiology.

[138]  S. Iversen,et al.  Failure of intravenous pentagastrin challenge to induce panic-like effects in rhesus monkeys , 1993, Neuropeptides.

[139]  J. Féger,et al.  The behavioral effects of CCK8 injected into the medial nucleus accumbens are dependent on the motivational state of the rat. , 1989, European journal of pharmacology.

[140]  G. Koob,et al.  Microinjections of nanogram amounts of sulfated cholecystokinin octapeptide into the rat nucleus accumbens attenuates brain stimulation reward , 1984, Neuroscience Letters.

[141]  J. Polak,et al.  Electron immunohistochemical evidence for the human intestinal I cell as the source of CCK. , 1978, Gut.

[142]  J. Morley,et al.  The effect of vagotomy on the satiety effects of neuropeptides and naloxone. , 1982, Life sciences.

[143]  M. Brownstein,et al.  The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay , 1981, Brain Research.

[144]  S. Dunnett,et al.  Dopamine and cholecystokinin immunoreactive neurones in mesencephalic grafts reinnervating the neostriatum: Evidence for selective growth regulation , 1984, Neuroscience.

[145]  J. Rehfeld,et al.  Ontogeny of procholecystokinin maturation in rat duodenum, jejunum, and ileum. , 1992, Gastroenterology.

[146]  S. Wank,et al.  Molecular cloning of the human brain and gastric cholecystokinin receptor: structure, functional expression and chromosomal localization. , 1992, Biochemical and biophysical research communications.

[147]  R. Corwin,et al.  Anorectic specificity as measured in a choice paradigm in rhesus monkeys , 1993, Pharmacology Biochemistry and Behavior.

[148]  G. P. Smith,et al.  Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. , 1981, Science.

[149]  R. Nesse,et al.  Cholecystokinin-4 and panic. , 1990, Archives of general psychiatry.

[150]  M. Beinfeld,et al.  Modulation of cholecystokinin release from posterior nucleus accumbens by D-2 dopamine receptor , 1986, Brain Research.

[151]  P. Riederer,et al.  Analysis of expression of cholecystokinin in dopamine cells in the ventral mesencephalon of several species and in humans with schizophrenia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[152]  F. Goodwin,et al.  Demonstration of a putative receptor site for cholecystokinin in rat brain , 1980, Neuropeptides.

[153]  P. Corringer,et al.  [3H]pBC 264, first highly potent and very selective radioligand for CCK-B receptors. , 1989, European journal of pharmacology.

[154]  H. Raybould,et al.  Mechanisms of action of peripherally administered cholecystokinin octapeptide on brain stem neurons in the rat , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[155]  R. Farmer,et al.  Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease , 1992 .

[156]  R. Liddle,et al.  Regulation of gastric emptying in humans by cholecystokinin. , 1986, The Journal of clinical investigation.

[157]  S. Paul,et al.  Postnatal ontogeny of cholecystokinin receptors in rat brain , 1981, Brain Research.

[158]  H. Bauer,et al.  Cholecystokinin decreases appetite and activation evoked by stimuli arising from the preparation of a meal in man , 1979, Physiology & Behavior.

[159]  K. Inouye,et al.  Memory effect of caerulein and its analogs in active and passive avoidance responses in the rat , 1989, Peptides.

[160]  T. Brewerton,et al.  CSF cholecystokinin octapeptide in patients with bulimia nervosa and in normal comparison subjects. , 1993, The American journal of psychiatry.

[161]  S. Berlangieri,et al.  Central and peripheral effects of CCK receptor antagonists on satiety in dogs. , 1993, The American journal of physiology.

[162]  J. Glowinski,et al.  Autoradiography of CCK receptors in the rat brain using [3H]Boc[Nle28 31]CCK27–33 and [125I]bolton-hunter CCK8. Functional significance of subregional distributions , 1987, Neurochemistry International.

[163]  P. McHugh,et al.  Gastric branch vagotomy blocks nutrient and cholecystokinin-induced suppression of gastric emptying. , 1993, The American journal of physiology.

[164]  M. Cullen,et al.  Centrally administered CCK-8 suppresses activity in mice by a “peripheral-type” CCK receptor , 1989, Pharmacology Biochemistry and Behavior.

[165]  K. Hermansen Effects of cholecystokinin (CCK)-4, nonsulfated CCK-8, and sulfated CCK-8 on pancreatic somatostatin, insulin, and glucagon secretion in the dog: studies in vitro. , 1984, Endocrinology.

[166]  P. Kerstens,et al.  Physiological plasma concentrations of cholecystokinin stimulate pancreatic enzyme secretion and gallbladder contraction in man. , 1985, Life sciences.

[167]  P. McHugh,et al.  Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK. , 1992, The American journal of physiology.

[168]  B. Roques,et al.  Cyclic cholecystokinin analogues with high selectivity for central receptors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[169]  R. Reidelberger,et al.  Potent cholecystokinin antagonist L 364718 stimulates food intake in rats. , 1989, The American journal of physiology.

[170]  C. Turkelson,et al.  A cholecystokinin-metabolizing enzyme in rat intestine , 1990, Peptides.

[171]  C. Beglinger,et al.  Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. , 1990, The Journal of clinical investigation.

[172]  J. Morley,et al.  Feeding systems in Chinese hamsters. , 1984, The American journal of physiology.

[173]  L. Rovati,et al.  CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man. , 1989, Gut.

[174]  S. Paul,et al.  CCK receptors and human neurological disease. , 1982, Life sciences.

[175]  T. Hökfelt,et al.  Evidence for coexistence of dopamine and CCK in meso-limbic neurones , 1980, Nature.

[176]  C. de Montigny,et al.  Long-term benzodiazepine treatment reduces neuronal responsiveness to cholecystokinin: an electrophysiological study in the rat. , 1988, European Journal of Pharmacology.

[177]  D. Farningham,et al.  Satiety signals in sheep: Involvement of CCK, propionate, and vagal CCK binding sites , 1993, Physiology & Behavior.

[178]  M. Anika Effects of cholecystokinin and caerulein on gastric emptying. , 1982, European journal of pharmacology.

[179]  R. Quirion,et al.  Cholecystokinin antagonists proglumide, lorglumide and benzotript, but not L-364,718, interact with brain opioid binding sites , 1990, Neuropeptides.

[180]  C. Baile,et al.  Meal-stimulated increased concentrations of CCK in the hypothalamus of Zucker obese and lean rats , 1985, Physiology & Behavior.

[181]  Y. Shinomura,et al.  Effect of cholecystokinin receptor antagonists, MK-329 and L-365,260, on cholecystokinin-induced acid secretion and histidine decarboxylase activity in the rat , 1991, Regulatory Peptides.

[182]  T. Hökfelt,et al.  Effect of cholecystokinin-octapeptide on dopamine release from slices of cat caudate nucleus , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[183]  J. Vanderhaeghen,et al.  Cholecystokinin receptors of A type in the human dorsal medulla oblongata and meningiomas, and of B type in small cell lung carcinomas , 1990, Neuroscience Letters.

[184]  L. Way Effect of cholecystokinin and caerulein on gastric secretion in cats. , 1971, Gastroenterology.

[185]  D. Hommer,et al.  Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtype , 1986, Journal of Neuroscience.

[186]  W. Chey,et al.  Actions and interactions of gut hormones and histamine on gastric secretion of acid in the rat. , 1973, The American journal of physiology.

[187]  J. Barrett,et al.  Evaluation of the effects of PD 134308 (CI-988), A CCK-B antagonist, on the punished responding of squirrel monkeys , 1991, Neuropeptides.

[188]  G. Katsuura,et al.  Protective effect of CCK-8 and ceruletide on glutamate-induced neuronal cell death in rat neuron cultures: Possible involvement of CCK-B receptors , 1991, Neuroscience Letters.

[189]  F. Mora,et al.  Peptides and self-stimulation of the medial prefrontal cortex in the rat: Effects of intracerebral microinjections of substance P and cholecystokinin , 1988, Peptides.

[190]  B. Penke,et al.  Degradation of cholecystokinin octapeptide by the neutral endopeptidase EC 3.4.24.11 and design of proteolysis-resistant analogues of the peptide , 1987, Neurochemistry International.

[191]  B. Roques,et al.  Enzyme-resistant CCK analogs with high affinities for central receptors , 1988, Peptides.

[192]  J. Vanderhaeghen,et al.  Opposite effects of cholecystokinin octapeptide (CCK-8) and tetrapeptide (CCK-4) after injection into the caudal part of the nucleus accumbens or into its rostral part and the cerebral ventricles , 1987, Neurochemistry International.

[193]  P. Södersten,et al.  Involvement of Cholecystokinin in Food Intake: I. Concentrations of Cholecystokinin‐Like Immunoreactivity in the Cerebrospinal Fluid of Male Rats , 1990, Journal of neuroendocrinology.

[194]  R. Innis,et al.  Cholecystokinin receptor binding in brain and pancreas: Regulation of pancreatic bindign by cyclic and acyclic guanine nucleotides , 1980 .

[195]  A. Tsuji,et al.  Effect of low-frequency electric stimulation on in vivo release of cholecystokinin-like immunoreactivity in medial thalamus of conscious rat , 1990, Neuroscience Letters.

[196]  G. P. Smith,et al.  Effect of cholecystokinin, gastrin, secretin and GIP on sham feeding in the rat , 1979, Physiology & Behavior.

[197]  J. Crawley Divergent effects of cholecystokinin, bombesin, and lithium on rat exploratory behaviors , 1983, Peptides.

[198]  H. Worning,et al.  Cholecystokinetic and pancreozymic effect of O-sulfated gastrin compared with nonsulfated gastrin and cholecystokinin. , 1986, Gastroenterology.

[199]  P. McHugh,et al.  Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches , 1987, Brain Research.

[200]  T. Moody,et al.  Growth factor and peptide receptors in small cell lung cancer. , 1993, Life sciences.

[201]  J. Howbert,et al.  Inhibition of A9 and A10 dopamine cells by the cholecystokinin‐B antagonist LY262691: Mediation through feedback pathways from forebrain sites , 1993, Synapse.

[202]  R. Hill,et al.  The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin , 1988, British journal of pharmacology.

[203]  S. Itoh,et al.  Specificity of nucleus accumbens to activities related to cholecystokinins in rats , 1985, Peptides.

[204]  T. Chase,et al.  Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy. , 1982, European journal of pharmacology.

[205]  J. Morley,et al.  Evidence for a physiological role for CCK in the regulation of food intake in mice. , 1989, The American journal of physiology.

[206]  J. Crawley Microinjection of cholecystokinin into the rat ventral tegmental area potentiates dopamine‐induced hypolocomotion , 1989, Synapse.

[207]  N. Bunnett,et al.  Intestinal acid inhibits gastric acid secretion by neural and hormonal mechanisms in rats. , 1992, The American journal of physiology.

[208]  S. Wank,et al.  Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[209]  J. Rehfeld,et al.  Identification of cholecystokinin/gastrin peptides in frog and turtle. Evidence that cholecystokinin is phylogenetically older than gastrin. , 1992, European journal of biochemistry.

[210]  Paul R. McHugh,et al.  Two brain cholecystokinin receptors: implications for behavioral actions , 1986, Brain Research.

[211]  S. Schiffmann,et al.  Cholecystokinin mRNA detection in rat spinal cord motoneurons but not in dorsal root ganglia neurons , 1991, Neuroscience Letters.

[212]  J. Rehfeld,et al.  N-Terminal fragments of intestinal cholecystokinin: evidence for release of CCK-8 by cleavage on the carboxyl side of Arg74 of proCCK , 1993, Regulatory Peptides.

[213]  A. Ivy,et al.  A HORMONE MECHANISM FOR GALL-BLADDER CONTRACTION AND EVACUATION , 1928 .

[214]  R. Corwin,et al.  Effects of cholecystokinin, d-amphetamine and fenfluramine in rats trained to discriminate 3 from 22 hr of food deprivation. , 1990, The Journal of pharmacology and experimental therapeutics.

[215]  C. Schneider,et al.  Ceruletide increases threshold and tolerance to experimentally induced pain in healthy man , 1982, Peptides.

[216]  E G Jones,et al.  Neuropeptide-containing neurons of the cerebral cortex are also GABAergic. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[217]  B. Bunney,et al.  Does the cholecystokinin antagonist proglumide possess antipsychotic activity? , 1986, Psychiatry Research.

[218]  P. McHugh,et al.  Integration of vagal afferent responses to gastric loads and cholecystokinin in rats. , 1991, The American journal of physiology.

[219]  V. Mutt,et al.  Structure of Porcine Cholecystokinin‐Pancreozymin , 1968 .

[220]  S. Itoh,et al.  Cholecystokinin tetrapeptide, proglumide and open-field behavior in rats. , 1984, Life sciences.

[221]  R. Jensen,et al.  Interactions of COOH-terminal fragments of cholecystokinin with receptors on dispersed acini from guinea pig pancreas. , 1982, The Journal of biological chemistry.

[222]  W. Millington,et al.  The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment , 1992, Neuropeptides.

[223]  J. Bradwejn,et al.  Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients. , 1994, The American journal of psychiatry.

[224]  J. Valenzuela,et al.  Cholecystokinin-octapeptidelike immunoreactivity in human plasma. , 1982, Gastroenterology.

[225]  E. Bouras,et al.  Evidence for indirect dietary regulation of cholecystokinin release in rats. , 1993, The American journal of physiology.

[226]  J. Crawley,et al.  Potency of L-364,718 as an antagonist of the behavioral effects of peripherally administered cholecystokinin. , 1988, Life sciences.

[227]  M. R. Hokin Studies on chemical mechanisms of the action of neurotransmitters and hormones. I. Relationship between hormone stimulated 32P incorporation into phosphatidic acid and into phosphatidylinositol in pigeon pancreas slices. , 1968, Archives of biochemistry and biophysics.

[228]  Jacqueline N. Crawley,et al.  Attenuation of dark-induced hyperlocomotion by a cholecystokinin antagonist in the nucleus accumbens , 1988, Brain Research.

[229]  J. Howbert,et al.  Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity. , 1991, European journal of pharmacology.

[230]  G. Böhme,et al.  ‘Anxiolytic’ effect of CCK-antagonists on plus-maze behavior in mice , 1991, Brain Research.

[231]  W. Oldendorf,et al.  Rapid appearance of intraventricularly administered neuropeptides in the peripheral circulation , 1982, Brain Research.

[232]  P. Verbanck,et al.  Reduced cholecystokinin immunoreactivity in the cerebrospinal fluid of patients with psychiatric disorders. , 1984, Life sciences.

[233]  B. Penke,et al.  Cataleptogenic and anticataleptic activity produced by cholecystokinin octapeptides in mice , 1985, Neuropeptides.

[234]  G. P. Smith,et al.  Cholecystokinin decreases food intake in rats. , 1973, Journal of comparative and physiological psychology.

[235]  N. Maidment,et al.  Dual determination of extracellular cholecystokinin and neurotensin fragments in rat forebrain: Microdialysis combined with a sequential multiple antigen radioimmunoassay , 1991, Neuroscience.

[236]  T. Hökfelt,et al.  Detection of cholecystokinin in spermatogenic cells. , 1988, Acta physiologica Scandinavica.

[237]  G. P. Smith,et al.  Different effects of CCK antagonists on gastric-acid response to CCK and pentagastrin , 1993, Peptides.

[238]  G. Debonnel,et al.  Effects of long-term haloperidol treatment on the responsiveness of accumbens neurons to cholecystokinin and dopamine: electrophysiological and radioligand binding studies in the rat , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[239]  T. Hökfelt,et al.  Immunocytochemical demonstration of cholecystokinin-like immunoreactivity in spermatozoa in monkey testis and epididymis. , 1989, Acta physiologica Scandinavica.

[240]  T. Yaksh,et al.  Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats — pharmacological characterization of this action , 1986, Regulatory Peptides.

[241]  J. Morley,et al.  Do peptide-induced changes in feeding occur because of changes in motivation to eat? , 1990, Peptides.

[242]  G. P. Smith,et al.  Proglumide fails to increase food intake after an ingested preload , 1986, Peptides.

[243]  J. Bradwejn,et al.  Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. , 1991, Archives of general psychiatry.

[244]  W. Millington,et al.  Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary. , 1992, The Journal of pharmacology and experimental therapeutics.

[245]  A. Steggles,et al.  Changes in Cholecystokinin receptor binding in rat brain after food deprivation , 1983, Brain Research.

[246]  The single-item meal as a measure of binge-eating behavior in patients with bulimia nervosa , 1992, Physiology & Behavior.

[247]  C. Dourish,et al.  Classification and function of CCK receptors , 1987 .

[248]  J. Gibbs,et al.  Vagotomy fails to block the satiating effect of food in the stomach , 1980, Physiology & Behavior.

[249]  F. Pi‐Sunyer,et al.  Cholecystokinin (CCK-8) affects gastric pressure and ratings of hunger and fullness in women. , 1992, The American journal of physiology.

[250]  J. Elashoff,et al.  Gastrin receptors on isolated canine parietal cells. , 1984, The Journal of clinical investigation.

[251]  R. Pullen,et al.  Penetration of diazepam and the non‐peptide CCK antagonist, L‐364, 718, into rat brain , 1987, The Journal of pharmacy and pharmacology.

[252]  J. Palacios,et al.  Beta adrenergic receptor localization in rat brain by light microscopic autoradiography , 1982, Neurochemistry International.

[253]  G. P. Smith,et al.  Increased food intake after type A but not type B cholecystokinin receptor blockade , 1991, Physiology & Behavior.

[254]  J. Ballenger,et al.  CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects. , 1992, The American journal of psychiatry.

[255]  B. Gorzalka,et al.  Cholecystokinin-octapeptide produces inhibition of lordosis in the female rat , 1984, Pharmacology Biochemistry and Behavior.

[256]  J. Morley,et al.  Modulation of memory processing by cholecystokinin: dependence on the vagus nerve. , 1987, Science.

[257]  R. Gingerich,et al.  Cholecystokinin concentration in specific brain areas of rats fed during the light or dark phase of the circadian cycle , 1989, Physiology & Behavior.

[258]  R. Mansbach,et al.  Cholecystokinin (CCK-8) elicits prandial sleep in rats , 1983, Physiology & Behavior.

[259]  G. P. Smith,et al.  Cholecystokinin-induced satiety depends on activation of 5-HT1C receptors. , 1993, The American journal of physiology.

[260]  G. P. Smith,et al.  Type-A CCK receptors mediate the inhibition of food intake and activity by CCK-8 in 9- to 12-day-old rat pups , 1991, Pharmacology Biochemistry and Behavior.

[261]  L. F. Kolakowski,et al.  The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization. , 1993, The Journal of biological chemistry.

[262]  M. Rogawski Cholecystokinin octapeptide: Effects on the excitability of cultured spinal neurons , 1982, Peptides.

[263]  S. Konturek,et al.  Role of cholecystokinin in the intestinal fat- and acid-induced inhibition of gastric secretion , 1992, Regulatory Peptides.

[264]  R. Murphy,et al.  Peripheral factors in the mediation of cholecystokinin-induced satiety as assessed by comparative potencies of cholecystokinin antagonists , 1992, Peptides.

[265]  G. Green,et al.  Plasma cholecystokinin and pancreatic growth during adaptation to dietary protein. , 1986, The American journal of physiology.

[266]  I. Goldfine,et al.  Characterization of Receptors for Cholecystokinin and Related Peptides in Mouse Cerebral Cortex , 1981, Journal of neurochemistry.

[267]  R. Young,et al.  Cholecystokinin elicits Satiety in Rats with Open Gastric Fistulas , 1973, Nature.

[268]  E. Stellar,et al.  Brain cholecystokinin as a satiety peptide , 1986, Physiology & Behavior.

[269]  Y. Agid,et al.  CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients , 1982, Brain Research.

[270]  I. Goldfine,et al.  Physiological concentrations of cholecystokinin stimulate amino acid-induced insulin release in humans. , 1987, The Journal of clinical endocrinology and metabolism.

[271]  S. Peikin,et al.  Trypsin inhibitor effects on food intake and weight gain in zucker rats , 1983, Physiology & Behavior.

[272]  C. Jacquot,et al.  Effects of a new cholecystokinin analogue (JMV 236) on food intake and brain monoamines in the rat , 1990, Neuropeptides.

[273]  M. Hamon,et al.  Opioid Control of the In Vitro Release of Cholecystokinin‐Like Material from the Rat Substantia Nigra , 1992, Journal of neurochemistry.

[274]  G. Shulman,et al.  Physiological Role of Cholecystokinin in Meal-Induced Insulin Secretion in Conscious Rats: Studies With L 364718, A Specific Inhibitor of CCK-Receptor Binding , 1987, Diabetes.

[275]  S. Cooper,et al.  Multiple cholecystokinin (CCK) receptors and CCK-monoamine interactions are instrumental in the control of feeding , 1990, Physiology & Behavior.

[276]  K. Terashi,et al.  Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas. , 1979, The Journal of clinical investigation.

[277]  J. Williams,et al.  Binding of cholecystokinin to high affinity receptors on isolated rat pancreatic acini. , 1980, The Journal of biological chemistry.

[278]  B. Komisaruk,et al.  Morphine analgesia potentiated but tolerance not affected by active immunization against cholecystokinin. , 1984, Science.

[279]  R. Ritter,et al.  Capsaicin application to central or peripheral vagal fibers attenuates CCK satiety , 1988, Peptides.

[280]  J. Harro,et al.  Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat. , 1991, European journal of pharmacology.

[281]  T. Hökfelt,et al.  Distribution of peptide- and catecholamine-containing neurons in the gastro-intestinal tract of rat and guinea-pig: Immunohistochemical studies with antisera to substance P, vasoactive intestinal polypeptide, enkephalins, somatostatin, gastrin/cholecystokinin, neurotensin and dopamine β-hydroxylase , 1980, Neuroscience.

[282]  T. Hökfelt,et al.  Distribution patterns of CCK and CCK mRNA in some neuronal and non-neuronal tissues , 1991, Neuropeptides.

[283]  S. Itoh,et al.  Effect of cholecystokinin octapeptide on body temperature in the rat. , 1981, The Japanese journal of physiology.

[284]  J. Kiss,et al.  Cholecystokinin in the Medial Parvocellular Subdivision of the Paraventricular Nucleus: Co‐existence with Corticotropin‐releasing Hormone , 1985, Annals of the New York Academy of Sciences.

[285]  D. Reis,et al.  Somatostatin and CCK-8 modulate release of striatal amino acids: Role of dopamine receptors , 1986, Peptides.

[286]  R. Liddle,et al.  Influence of food deprivation on intestinal cholecystokinin and somatostatin. , 1991, Gastroenterology.

[287]  B. Roques,et al.  Evidence for an endogenous cholecystokininergic balance in social memory. , 1992, Neuroreport.

[288]  R. Spealman Failure of cholecystokinin antagonists to modify the discriminative stimulus effects of cocaine , 1992, Pharmacology Biochemistry and Behavior.

[289]  J. D. De Mey,et al.  Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[290]  J. Crawley,et al.  Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[291]  G. Woodruff,et al.  Autoradiographical detection of cholecystokinin-A receptors in primate brain using 125I-Bolton Hunter CCK-8 and 3H-MK-329 , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[292]  J. Jansen,et al.  Physiological role and localization of cholecystokinin release in dogs. , 1986, The American journal of physiology.

[293]  F. Makovec,et al.  Different peripheral and central antagonistic activity of new glutaramic acid derivatives on satiety induced by cholecystokinin in rats , 1986, Regulatory Peptides.

[294]  J. Carter,et al.  Dietary regulation of rat intestinal cholecystokinin gene expression. , 1988, The Journal of clinical investigation.

[295]  J. Palacios,et al.  Does cholecystokinin colocalize with dopamine in the human substantia nigra? , 1989, Brain Research.

[296]  K. Shimizu,et al.  Effect of CCK Antagonists CR 1409 and CR 1505 on Rat Pancreatic Exocrine Secretion In Vivo , 1989, Pancreas.

[297]  G. Sedvall,et al.  CCK peptides and mRNA in the human brain , 1993, Progress in Neurobiology.

[298]  C. Montigny,et al.  Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones , 1984, Nature.

[299]  F. Pi‐Sunyer,et al.  Effect of a soup preload on reduction of food intake by cholecystokinin in humans. , 1991, The American journal of physiology.

[300]  J. Morley,et al.  Minireview. The ascent of cholecystokinin (CCK) - from gut to brain. , 1982, Life sciences.

[301]  S. Reines,et al.  A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder , 1992, Biological Psychiatry.

[302]  R. Ritter,et al.  Trypsin inhibitor and maternal reunion increase plasma cholecystokinin in neonatal rats , 1992, Peptides.

[303]  S. Caccia,et al.  Reciprocal interaction of 5‐hydroxytryptamine and cholecystokinin in the control of feeding patterns in rats , 1993, British journal of pharmacology.

[304]  B. Hoffman,et al.  Cloned cDNA to cholecystokinin mRNA predicts an identical preprocholecystokinin in pig brain and gut. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[305]  L. Chiodo,et al.  Electrophysiological effects of cholecystokinin octapeptide on identified rat nigrostriatal dopaminergic neurons , 1988, Brain Research.

[306]  V. Go,et al.  In vivo studies on the basal and evoked release of cholecystokinin and vasoactive intestinal polypeptide from cat cerebral cortex and periventricular structures , 1983, Brain Research.

[307]  T. Hökfelt,et al.  Transient expression of the cholecystokinin gene in male germ cells and accumulation of the peptide in the acrosomal granule: possible role of cholecystokinin in fertilization. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[308]  R. Hill,et al.  Reduction of food intake by central administration of cholecystokinin octapeptide in the rat is dependent upon inhibition of brain peptidases , 1989, British journal of pharmacology.

[309]  P. Södersten,et al.  Sexual activity increases plasma concentrations of cholecystokinin octapeptide and offsets hunger in male rats. , 1987, The Journal of endocrinology.

[310]  R. Woutersen,et al.  Cholecystokinin and gastrointestinal cancer , 1990, The Journal of Steroid Biochemistry and Molecular Biology.

[311]  D. Niehoff Quantitative autoradiographic localization of cholecystokinin receptors in rat and guinea pig brain using 125I-Bolton-Hunter-CCK8 , 1989, Peptides.

[312]  D. de Wied,et al.  In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents. , 1983, European journal of pharmacology.

[313]  F. Pi‐Sunyer,et al.  Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men. , 1992, The American journal of physiology.

[314]  C. Pert,et al.  Tritium-sensitive film autoradiography of [3H]cholecystokinin-5/pentagastrin receptors in rat brain. , 1983, European journal of pharmacology.

[315]  R. Innis,et al.  Cholecystokinin receptors: presence and axonal flow in the rat vagus nerve. , 1981, Life sciences.

[316]  C. Montigny,et al.  Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings. , 1989 .

[317]  M. J. Shaw,et al.  Species Differences in the Response to Cholecystokinin , 1985, Annals of the New York Academy of Sciences.

[318]  S. Paul,et al.  Vagotomy abolishes the inhibitory effects of cholecystokinin on rat exploratory behaviors , 1981 .

[319]  B. Costall,et al.  Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[320]  B. Gertz,et al.  Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK. , 1989, The Journal of clinical investigation.

[321]  J. Glowinski,et al.  Cholecystokinin: Corelease with dopamine from nigrostriatal neurons in the cat , 1989, The European journal of neuroscience.

[322]  P. Hamosh,et al.  Respiratory and cardiovascular effects of intraventricular cholecystokinin. , 1982, European journal of pharmacology.

[323]  V. J. Lotti,et al.  Fasting and L-364,718 prevent cholecystokinin-induced elevations of plasma insulin levels. , 1987, European journal of pharmacology.

[324]  J. Morley,et al.  Intraventricular cholecystokinin-octapeptide produces hypothermia in rats. , 1981, European journal of pharmacology.

[325]  A. Akaike,et al.  Cholecystokinin-induced protection of cultured cortical neurons against glutamate neurotoxicity , 1991, Brain Research.

[326]  A. Sclafani,et al.  Cholecystokinin conditions flavor preferences in rats. , 1991, The American journal of physiology.

[327]  J. Williams,et al.  Evidence That Cholecystokinin Interacts with Specific Receptors and Regulates Insulin Release in Isolated Rat Islets of Langerhans , 1986, Diabetes.

[328]  J. Kelly,et al.  Cholecystokinin and gastrin as transmitters in the mammalian central nervous system. , 1981, Advances in biochemical psychopharmacology.

[329]  A. Kopin,et al.  A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists , 1993, Nature.

[330]  J. Crawley,et al.  Microdialysis as an approach to quantitate the release of neuropeptides , 1990, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[331]  J. Elashoff,et al.  Cholecystokinin potently releases somatostatin from canine fundic mucosal cells in short-term culture. , 1985, The American journal of physiology.

[332]  J. Vanderhaeghen,et al.  High concentration of cholecystokinin neurons in the newborn human entorhinal cortex , 1987, Neuroscience Letters.

[333]  G. P. Smith,et al.  Ceruletide acts in the abdomen, not in the brain, to produce satiety , 1984, Peptides.

[334]  J. Crawley,et al.  Paraventricular nucleus lesions abolish the inhibition of feeding induced by systemic cholecystokinin , 1985, Peptides.

[335]  J. Harro,et al.  Age-related differences of cholecystokinin receptor binding in the rat brain , 1992, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[336]  J. Schwaber,et al.  Abolition of the behavioral effects of cholecystokinin following bilateral radiofrequency lesions of the parvocellular subdivision of the nucleus tractus solitarius , 1984, Brain Research.

[337]  J. Fudge,et al.  Scheduled running wheel activity indexes the specificity of pharmacological anorexia. , 1992, Behavioral and neural biology.

[338]  M. Palkovits,et al.  Cholecystokinin-induced excitation in the substantia nigra: evidence for peripheral and central components , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[339]  F. Kraly Vagotomy does not alter cholecystokinin's inhibition of sham feeding. , 1984, The American journal of physiology.

[340]  C. Niederau,et al.  Cholecystokinin does not delay gastric emptying of regular meals in healthy humans. , 1993, Hepato-gastroenterology.

[341]  T. Geracioti,et al.  Impaired cholecystokinin secretion in bulimia nervosa. , 1988, The New England journal of medicine.

[342]  G. Zetler Cholecystokinin octapeptide, caerulein and caerulein analogues: Effects on thermoregulation in the mouse , 1982, Neuropharmacology.

[343]  U. Ungerstedt,et al.  Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbens using intracerebral dialysis in the anaesthetized rat , 1987, Neurochemistry International.

[344]  D. Jaffe,et al.  The effects of cholecystokinin and cholecystokinin antagonists on synaptic function in the CA1 region of the rat hippocampal slice , 1987, Brain Research.

[345]  L. Watkins,et al.  Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. , 1983, Science.

[346]  C. Blaha,et al.  Reversal by cholecystokinin of apomorphine-induced inhibition of dopamine release in the nucleus accumbens of the rat , 1987, Regulatory Peptides.

[347]  J. Han,et al.  Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord. , 1993, European journal of pharmacology.

[348]  T. T. Survill,et al.  The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans. , 1992, Gastroenterology.

[349]  L. Watkins,et al.  Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates , 1985, Brain Research.

[350]  P. Eneroth,et al.  Stimulation of Maternal Behaviour in Rats with Cholecystokinin Octapeptide , 1989, Journal of neuroendocrinology.

[351]  J. Crawley,et al.  Potency of CR 1409, a new proglumide analog, on cholecystokinin-mediated behaviors and receptor binding , 1987, Neurochemistry International.

[352]  S. Iversen,et al.  The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat. , 1990, European journal of pharmacology.

[353]  G. Dockray,et al.  Gastric emptying in rats: role of afferent neurons and cholecystokinin. , 1990, The American journal of physiology.

[354]  V. Mutt,et al.  Cholecystokinin and pancreozymin, one single hormone? , 1966, Acta physiologica Scandinavica.

[355]  B. A. Baldwin,et al.  Effects of the CCK receptor antagonist MK-329 on food intake in pigs , 1990, Physiology & Behavior.

[356]  K. Simansky,et al.  The CCK-A receptor antagonist, devazepide, blocks the anorectic action of CCK but not peripheral serotonin in rats , 1992, Pharmacology Biochemistry and Behavior.

[357]  T. Salt,et al.  The effects of C-terminal fragments of cholecystokinin on the firing of single neurones in the caudal trigeminal nucleus of the rat , 1982, Neuropeptides.

[358]  S. Iversen,et al.  Evidence that decreased feeding induced by systemic injection of cholecystokinin is mediated by CCK-A receptors. , 1989, European journal of pharmacology.

[359]  M. Demitrack,et al.  Regulation of appetite and cholecystokinin secretion in anorexia nervosa. , 1992, The American journal of psychiatry.

[360]  M. Galas,et al.  Pharmacological characterization of new cholecystokinin analogues. , 1992, European journal of pharmacology.

[361]  A. Scallet,et al.  Satiety, hunger and regional brain content of cholecystokinin/gastrin and met-enkephalin immunoreactivity in sheep , 1985, Peptides.

[362]  G. Eberlein,et al.  Cholecystokinin-58 is the major molecular form in man, dog and cat but not in pig, beef and rat intestine , 1988, Peptides.

[363]  I. Goldfine,et al.  Cholecystokinin receptors in the brain: characterization and distribution. , 1980, Science.

[364]  P. Anderson,et al.  Effects of non-peptidal CCK receptor antagonist (L-364,718) on pancreatic responses to cholecystokinin, gastrin, bombesin, and meat feeding in dogs. , 1989, Gut.

[365]  T. Hökfelt,et al.  Immunohistochemical studies on cholecystokinin (CCK)-immunoreactive neurons in the rat using sequence specific antisera and with special reference to the caudate nucleus and primary sensory neurons. , 1988, Journal of chemical neuroanatomy.

[366]  J. Crawley,et al.  Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism. , 1991, The Journal of pharmacology and experimental therapeutics.

[367]  M. Randić,et al.  Cholecystokinin octapeptide excites dorsal horn neurons both in vivo and in vitro , 1981, Brain Research.

[368]  D. Gully,et al.  Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors. , 1993, European journal of pharmacology.

[369]  J. Beck,et al.  Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man. , 1969, The Journal of clinical investigation.

[370]  J. Crawley,et al.  Analysis of the behavioral activity of C- and N-terminal fragments of cholecystokinin octapeptide. , 1984, The Journal of pharmacology and experimental therapeutics.

[371]  J. Harro,et al.  Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain. , 1990, European journal of pharmacology.

[372]  L. Johnson,et al.  Effect of Secretin and Cholecystokinin on the Response of the Gastric Fistula Rat to Pentagastrin , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[373]  J. Crawley,et al.  Electroencephalographic analysis of the sleep-inducing actions of cholecystokinin , 1982, Neuropeptides.

[374]  F. Marshall,et al.  Cholecystokinin Modulates the Release of Dopamine from the Anterior and Posterior Nucleus Accumbens by Two Different Mechanisms , 1991, Journal of neurochemistry.

[375]  S. Iversen,et al.  Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718. , 1988, European journal of pharmacology.

[376]  Wormsley Kg Gastric response to secretin and pancreoxymin in man. , 1968 .

[377]  J. A. Deutsch,et al.  An antiemetic is antidotal to the satiety effects of cholecystokinin , 1985, Nature.

[378]  J. Palacios,et al.  Regional distribution of the messenger RNA coding for the neuropeptide cholecystokinin in the human brain examined by in situ hybridization. , 1990, Brain research. Molecular brain research.

[379]  T. Yaksh,et al.  Sites in the brain at which cholecystokinin octapeptide (CCK-8) acts to suppress feeding in rats: A mapping study , 1990, Neuropharmacology.

[380]  P. Somogyi,et al.  Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin- immunoreactive material , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[381]  Steven A. Goldman,et al.  Vagal mediation of the cholecystokinin satiety effect in rats , 1982, Physiology & Behavior.

[382]  J. Mercer,et al.  Selectivity of cholecystokinin (CCK) receptor antagonists, MK-329 and L-365,260, for axonally-transported CCK binding sites on the rat vagus nerve , 1992, Neuroscience Letters.

[383]  S. Cooper,et al.  Reversal of the anorectic effect of (+)‐fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK‐329 , 1990, British journal of pharmacology.

[384]  G. P. Smith,et al.  Devazepide antagonizes the inhibitory effect of cholecystokinin on intake in sham-feeding rats , 1992, Pharmacology Biochemistry and Behavior.

[385]  F. Goodwin,et al.  Cholecystokinin reduces exploratory behavior in mice , 1981, Physiology & Behavior.

[386]  J. Schwartz,et al.  Assessment of the role of “enkephalinase” in cholecystokinin inactivation , 1985, Neuroscience.

[387]  R. Ritter,et al.  Low-dose near-celiac arterial cholecystokinin suppresses food intake in rats. , 1992, The American journal of physiology.

[388]  L. Johnson,et al.  Effect of cholecystokinin and caerulein on gastrin- and histamine-evoked gastric secretion. , 1969, Gastroenterology.

[389]  T. Hökfelt,et al.  Distribution of Cholecystokinin‐like Immunoreactivity in the Nervous System , 1985 .

[390]  R. Nustede,et al.  Feedback Regulation of Exocrine Pancreatic Secretion in Dogs , 1993, Pancreas.

[391]  R. Shamburek,et al.  Control of acid secretion. , 1990, Gastroenterology clinics of North America.

[392]  F. Vaccarino,et al.  Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function. , 1989, Behavioral neuroscience.

[393]  G. P. Smith,et al.  Endogenous cholecystokinin reduces feeding in young rats. , 1990, Science.

[394]  G. P. Smith,et al.  The 5-HT1A agonist 8-OH-DPAT attenuates the satiating action of cholecystokinin , 1992, Pharmacology Biochemistry and Behavior.

[395]  M. Verhage,et al.  Characterization of the Release of Cholecystokinin‐8 from Isolated Nerve Terminals and Comparison with Exocytosis of Classical Transmitters , 1991, Journal of neurochemistry.

[396]  D. Hommer,et al.  Chapter 25 Functional studies of cholecystokinin-dopamine coexistence: electrophysiology and behavior , 1986 .

[397]  G. Woodruff,et al.  The behavioural properties of CI‐988, a selective cholecystokininB receptor antagonist , 1991, British journal of pharmacology.

[398]  J. Liebman,et al.  Antagonism of morphine analgesia by CCK-8-S does not extend to all assays nor all opiate analgesics , 1988, Peptides.

[399]  C. Beglinger,et al.  Pancreatic enzyme response to a liquid meal and to hormonal stimulation. Correlation with plasma secretin and cholecystokinin levels. , 1985, The Journal of clinical investigation.

[400]  T. Moran,et al.  Characterization of type A and type B CCK receptor binding sites in rat vagus nerve , 1993, Brain Research.

[401]  Grossman Mi,et al.  Gastrin-related peptides as stimulants of pancreatic and gastric secretion. , 1969 .

[402]  I. Goldfine,et al.  Bioassay of plasma cholecystokinin in rats: Effects of food, trypsin inhibitor, and alcohol , 1984 .

[403]  R. Mishra,et al.  Effects of unilateral intracerebroventricular microinjections of cholecystokinin (CCK) on circling behavior of rats , 1987, Peptides.

[404]  R. Deschenes,et al.  Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[405]  J. Rehfeld,et al.  Peptide-monoamine coexistence: Studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons , 1981, Neuroscience.

[406]  J. Palacios,et al.  The colocalization of cholecystokinin and tyrosine hydroxylase mRNAs in mesencephalic dopaminergic neurons in the rat brain examined byin situ hybridization , 1989, Neuroscience.

[407]  S. Paul,et al.  Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[408]  L. Rovati,et al.  Cholecystokinin in the inhibition of gastric secretion and gastric emptying in humans. , 1990, Digestion.

[409]  B. Bianchi,et al.  Pharmacological and mechanistic studies of cholecystokinin-facilitated [3H]dopamine efflux from rat nucleus accumbens , 1989, Neuropeptides.

[410]  G. P. Smith,et al.  Cholecystokinin elicits the complete behavioral sequence of satiety in rats. , 1975, Journal of comparative and physiological psychology.

[411]  J. Glowinski,et al.  Biochemical investigation on the localization of the cholecystokinin octapeptide in dopaminergic neurons originating from the ventral tegmental area of the rat , 1981, Neuropeptides.

[412]  P. Micevych,et al.  Injections of cholecystokinin into the ventromedial hypothalamic nucleus inhibit lordosis behavior in the rat , 1988, Physiology & Behavior.

[413]  A. Vaccarino,et al.  Antagonism of cholecystokinin function in the rostral and caudal nucleus accumbens: Differential effects on brain stimulation reward , 1989, Neuroscience Letters.

[414]  G. Zetler Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidol , 1981, Neuropharmacology.

[415]  G. Woodruff,et al.  Pharmacology of a cholecystokinin receptor on 5‐hydroxytryptamine neurones in the dorsal raphe of the rat brain , 1991, British journal of pharmacology.

[416]  J. A. Deutsch,et al.  Cholecystokinin produces bait shyness in rats , 1977, Nature.

[417]  G. Woodruff,et al.  Functional role of brain CCK receptors , 1991, Neuropeptides.

[418]  K. Mueller,et al.  Specificity of cholecystokinin satiety effect: Reduction of food but not water intake , 1977, Pharmacology Biochemistry and Behavior.

[419]  M. Bock,et al.  Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand. , 1989, Molecular pharmacology.

[420]  R. Ritter,et al.  Capsaicin attenuates hindbrain neuron responses to circulating cholecystokinin. , 1989, The American journal of physiology.

[421]  G. Dockray,et al.  Immunochemical Characterization of Peptides in Endocrine Cells and Nerves with Particular Reference to Gastrin and Cholecystokinin , 1981 .

[422]  J. Morley,et al.  Naloxone but not CCK-8 may attenuate binge-eating behavior in patients with the bulimia syndrome , 1986, Biological Psychiatry.

[423]  S. Nicolaı̈dis,et al.  Does cholecystokinin induce physiological satiety and sleep? , 1989, Brain Research.

[424]  G. Zetler Anticonvulsant effects of careulein and cholecystokinin octapeptide, compared with those of diazepam. , 1980, European journal of pharmacology.

[425]  J. Rossier,et al.  Inhibitory effect of cholecystokinin octapeptide on neurons in the nucleus tractus solitarius , 1983, Brain Research.

[426]  M. Beinfeld,et al.  Concentration of cholecystokinin in cerebrospinal fluid is decreased in psychosis: Relationship to symptoms and drug response , 1991, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[427]  Population response of midbrain dopaminergic neurons to neuroleptics: further studies on time course and nondopaminergic neuronal influences , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[428]  G. P. Smith,et al.  Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats. , 1985, The American journal of physiology.

[429]  R. Chang,et al.  A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. , 1989, European journal of pharmacology.

[430]  T. Hökfelt,et al.  Coexistence of substance P- and cholecystokinin-like immunoreactivity in neurons of the mesencephalic periaqueductal central gray , 1982, Neuroscience Letters.

[431]  T. Gettys,et al.  Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist. , 1990, The Journal of clinical endocrinology and metabolism.

[432]  J. Haycock,et al.  Ventral mesencephalic neurons containing both cholecystokinin‐ and tyrosine hydroxylase‐like immunoreactivities project to forebrain regions , 1989, The Journal of comparative neurology.

[433]  F. Goodwin,et al.  Cholecystokinin receptors are decreased in basal ganglia and cerebral cortex of Huntington's disease , 1981, Brain Research.

[434]  G. P. Smith,et al.  C-terminal octapeptide of cholecystokinin decreases food intake in man. , 1981, The American journal of clinical nutrition.

[435]  T. Nolan,et al.  Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonist. , 1987, The Journal of pharmacology and experimental therapeutics.

[436]  B. Costall,et al.  Anxiolytic effects of CCK-B antagonists , 1991, Neuropeptides.

[437]  R. J. Crosby,et al.  Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers , 1990, Brain Research.

[438]  R. Lyman,et al.  Feedback Regulation of Pancreatic Enzyme Secretion as a Mechanism for Trypsin Inhibitor-Induced Hypersecretion in Rats 1 , 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[439]  L. F. Kolakowski,et al.  Expression cloning and characterization of the canine parietal cell gastrin receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[440]  P. Micevych,et al.  Development of the limbic-hypothalamic cholecystokinin circuit: a model of sexual differentiation. , 1992, Developmental neuroscience.

[441]  P. Kalivas,et al.  Influence of cholecystokinin on central monoaminergic pathways , 1983, Regulatory Peptides.

[442]  B. E. Evans,et al.  Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260. , 1989, Journal of medicinal chemistry.

[443]  H. Raybould Capsaicin-sensitive vagal afferents and CCK in inhibition of gastric motor function induced by intestinal nutrients , 1991, Peptides.

[444]  F. Weiss,et al.  Opposite actions of CCK-8 on amphetamine-induced hyperlocomotion and stereotypy following intracerebroventricular and intra-accumbens injections in rats , 1988, Pharmacology Biochemistry and Behavior.

[445]  M. R. Hokin Studies on chemical mechanisms of the action of neurotransmitters and hormones. II. Increased incorporation of 32P into phosphatides as a second, adaptive response to pancreozymin or acetylcholine in pigeon pancreas slices. , 1968, Archives of biochemistry and biophysics.

[446]  D. Hommer,et al.  Cholecystokinin-like peptides potentiate apomorphine-induced inhibition of dopamine neurons. , 1983, European journal of pharmacology.

[447]  K. Winckler,et al.  Influence of repeated administration of cholecystokinin and secretin on the pancreas of the rat. , 1978, Scandinavian journal of gastroenterology.

[448]  E. Stricker,et al.  Capsaicin pretreatment attenuates multiple responses to cholecystokinin in rats. , 1988, Journal of the autonomic nervous system.

[449]  B. Bianchi,et al.  Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists. , 1990, Journal of medicinal chemistry.

[450]  James E. McGuigan,et al.  Cholecystokinin, vasoactive intestinal peptide and peptide histidine methionine responses to feeding in anorexia nervosa , 1991, Regulatory Peptides.

[451]  T. Berzin,et al.  Diseases of the pancreas , 2022, Pathy's Principles and Practice of Geriatric Medicine.

[452]  H. T. Debas,et al.  Cholecystokinin inhibits gastric emptying by acting on both proximal stomach and pylorus. , 1978, The American journal of physiology.

[453]  P. McHugh,et al.  Cholecystokinin suppresses food intake by inhibiting gastric emptying. , 1982, The American journal of physiology.

[454]  M. Palkovits,et al.  Distribution of cholecystokinin (CCK) in the rat lower brain stem nuclei , 1982, Brain Research.

[455]  T. Hökfelt,et al.  Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat , 1993, Neuroscience Letters.

[456]  D. Hommer,et al.  Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide. , 1986, The Journal of pharmacology and experimental therapeutics.

[457]  E. Corazziari,et al.  Effect of ninety-five percent pure cholecystokinin on gastrin-stimulated acid secretion in man and dog. , 1979, Gastroenterology.

[458]  J. Morley,et al.  Are peptides truly satiety agents? A method of testing for neurohumoral satiety effects. , 1983, The American journal of physiology.

[459]  H. Weingarten,et al.  Gastric emptying changes are neither necessary nor sufficient for CCK-induced satiety. , 1989, The American journal of physiology.

[460]  M. Takita,et al.  In vivo release of cholecystokinin-like immunoreactivity in rat frontal cortex under freely moving conditions , 1989, Neuroscience Letters.

[461]  V. Go,et al.  Release of cholecystokinin from rat cerebral cortex in vivo: role of GABA and glutamate receptor systems , 1987, Brain Research.

[462]  Manuel F. Gonzalez,et al.  The induction and suppression of c-fos expression in the rat brain by cholecystokinin and its antagonist L364,718 , 1993, Neuroscience Letters.

[463]  R. Gorski,et al.  Cholecystokinin stimulates and inhibits lordosis behavior in female rats , 1987, Physiology & Behavior.

[464]  C. Turkelson,et al.  Role of cholecystokinin in intestinal phase and meal-induced pancreatic secretion. , 1989, The American journal of physiology.

[465]  S. Ceccatelli,et al.  A subpopulation of dopaminergic neurons in rat ventral mesencephalon contains both neurotensin and cholecystokinin , 1988, Brain Research.

[466]  J. Lauterborn,et al.  Co-localization of enkephalin and cholecystokinin in discrete areas of rat brain , 1987, Brain Research.

[467]  M. Beinfeld CCK mRNA expression, pro-CCK processing, and regulated secretion of immunoreactive CCK peptides by rat insulinoma (RIN 5F) and mouse pituitary tumor (AtT-20) cells in culture , 1992, Neuropeptides.

[468]  S. Schiffmann,et al.  Cholecystokinin distribution in the human striatum and related subcortical structures , 1989, Neurochemistry International.

[469]  P. Ameglio,et al.  Endogenous cholecystokinin in the control of gastric emptying of liquid nutrient loads in rhesus monkeys. , 1993, American Journal of Physiology.

[470]  P. Frey Cholecystokinin octapeptide (CCK 26–33), nonsulfated octapeptide and tetrapeptide (CCK 30–33) in rat brain: Analysis by high pressure liquid chromatography (HPLC) and radioimmunoassay (RIA) , 1983, Neurochemistry International.

[471]  J. Harro,et al.  Cholecystokinin receptors and memory: A radial maze study , 1993, Pharmacology, Biochemistry and Behavior.

[472]  G. P. Smith,et al.  Cholecystokinin does not produce bait shyness in rats. , 1974, Physiology & behavior.

[473]  Gerard P. Smith,et al.  Hepatic-portal infusion reduces the satiating potency of CCK-8 , 1988, Physiology & Behavior.

[474]  R. Jensen,et al.  8 – Cholecystokinin Receptor Antagonists: Ability to Distinguish Various Classes of Cholecystokinin Receptors , 1990 .

[475]  L. Chiodo,et al.  Release of cholecystokinin from rat midbrain slices and modulatory effect of D2 DA receptor stimulation , 1991, Brain Research.

[476]  C. Beglinger,et al.  Role of circulating cholecystokinin in control of fat-induced inhibition of food intake in humans. , 1992, Gastroenterology.

[477]  J. Polak,et al.  IDENTIFICATION OF CHOLECYSTOKININ-SECRETING CELLS , 1975, The Lancet.